Newsroom Stories

All degree-seeking WashU students are encouraged to participate in a new survey about the campus climate.

With $1.5 million from the U.S. Department of Energy, a collaborative team of researchers led by the McKelvey School of Engineering is working toward creating efficient and reliable batteries for transportation use.

Scientists at Washington University School of Medicine in St. Louis have found that brain waves help flush waste out of the brain during sleep. The findings could lead to new approaches for treating Alzheimer’s disease and other neurological conditions.

The Alabama Supreme Court’s recent decision that frozen embryos are “extrauterine children” will have far-reaching implications in the state and beyond, said an expert on family law and reproductive justice at Washington University in St. Louis.

Washington University School of Medicine in St. Louis is one of seven U.S. institutions joining a new national clinical trials network launched by the National Cancer Institute, part of the National Institutes of Health (NIH), to investigate emerging technologies for cancer screening, with the goal of reducing cancer-related illnesses and deaths.

New research by Hannah Birnbaum at Olin Business School finds that one reason why more people in advantaged groups — particularly men and white people — do not engage in acts of allyship is because they underestimate how their actions will be appreciated by members of disadvantaged groups.

A new study by Margot Moinester in Arts & Sciences is among the first to find positive health benefits associated with inclusive immigration policies — a sharp contrast to the harmful effects of restrictive policies.

Neurologist Yo-El Ju, MD, a physician-scientist whose discoveries have illuminated the complex relationship between sleep and neurodegenerative disease, has been named an inaugural Barbara Burton and Reuben M. Morriss III Professor at Washington University School of Medicine in St. Louis.

GatewaySeq, a genetic test that identifies cancer mutations in solid tumors and that was developed by researchers at Washington University School of Medicine in St. Louis, has been approved for reimbursement by the Centers for Medicare & Medicaid Services.

Researchers at Washington University School of Medicine in St. Louis and Lund University in Sweden showed that a blood test is as good at identifying people in early stages of the disease as cerebrospinal fluid tests approved by the Food and Drug Administration for Alzheimer’s diagnosis.